We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Neurodegeneration – News and Features

News

Power3 Medical and NeoGenomics to Form Contract Research Organization

Parties to commercialize Power3’s blood-based tests for breast cancer, Alzheimer’s, ALS and Parkinson’s diseases.
News

Research Project Tackles 'Regeneration' Gap

Effort aims to learn nature's secrets of regeneration to treat human disorders.
News

Illumina Technology Uncovers Genetic Risk Factors Associated with Prostate Cancer and Lou Gehrig's Disease

New findings published in leading science journals, Nature Genetics and Lancet Neurology.
News

PerkinElmer Acquires Improvision Ltd.

This announcement builds upon PerkinElmer's recent acquisition of Evotec Technologies, a provider of high-performance cellular screening systems.
News

Manchester First for UK Biobank

A multi-million pound visionary medical project that will recruit 500,000 people across Britain to help find out much more about curing many life threatening and debilitating diseases gets underway in Manchester.
News

Arrowhead to Form New Nanomedicine Subsidiary and Acquire Nanotherapeutics Company, C Sixty

The new subsidary joins Arrowhead as its third focused on nanomedicine.
News

NeoStem Announces Launch of Third Stem Cell Collection Center

The Pennsylvania center will represent NeoStem’s strategic plan to generate revenues from nationwide network targeting projected $8.5 billion market.
News

Millipore and Aruna Biomedical Announce Licensing Agreement for ENStem™ Human Embryonic Neural Stem Cells

Millipore has acquired an exclusive worldwide license to distribute the ENStem neural progenitor cells derived from NIH-registered human embryonic stem cells.
News

Chemical cues Turn Embryonic Stem Cells into Cerebellar Neurons

A research study in mice at Rockfeller University shows that embryonic stem cells implanted in the brain appear to develop into fully differentiated granule neurons.
News

Evotec and Boehringer Ingelheim Enter into Target Discovery Collaboration in Alzheimer’s Disease

Both companies have signed a multi-year collaboration to jointly identify targets for the treatment of Alzheimer’s disease with the Research Institute of Molecular Pathology in Vienna.
Advertisement